Trial Condition(s):

Diagnostic Imaging

Observational study of Ultravist in patients requiring CECT (INDEX)

Bayer Identifier:

15515

ClinicalTrials.gov Identifier:

NCT01415414

EudraCT Number:

Not Available

Study Completed

Trial Purpose

It is a prospective, non-interventional, multi-center study. The primary objective of this study is to evaluate the image quality of Ultravist in patients requiring contrast-enhanced CT considering the routine use in patient population's, region's indication.

Inclusion Criteria
- Patients undergoing contrast enhanced CT Imaging with Ultravist (iopromide) in abdomen or pelvis.
Exclusion Criteria
- There is no other exclusion criteria beyond the contraindications contained in the Summary of Product Characteristics

Trial Summary

Enrollment Goal
11660
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Ultravist (Iopromide, BAY86-4877)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many locations, China

Status
Completed
 

Trial Design